The Rising Urgency in Liver Disease Research
Chronic liver diseases—including NASH, NAFLD, cirrhosis, and viral hepatitis—are among the fastest-growing global health burdens. With obesity, diabetes, and alcohol-related disorders on the rise, demand for hepatology trials has surged. Yet despite this need, recruitment remains one of the field’s most persistent challenges.
Patients are often asymptomatic until advanced disease stages, leaving many unaware of their eligibility for clinical research. Complex protocols, privacy concerns, and long follow-up timelines only add to the burden for sponsors and sites.
OMNI CRS provides a better path forward—turning complex hepatology enrollment into a data-driven, compliant, and human-centered process.
Accelerating Hepatology Enrollment Through Data and Trust Building
OMNI CRS accelerates hepatology recruitment with precision, compliance, and technology engineered for performance.
Our multi-channel marketing engine uses predictive modeling, automated pre-screening, and geo-targeted outreach to reach qualified participants early—often before diagnosis or referral.
We specialize in chronic and complex disease recruitment, driving results across 35+ therapeutic areas and 150+ indications, including liver and metabolic disorders.
Proven Impact in Autoimmune & Rheumatology Research
Working with OMNI CRS delivers measurable outcomes:
Proven experience
in NASH, NAFLD, hepatitis, and cirrhosis recruitment
Data-validated outreach
that identifies at-risk, undiagnosed populations
Faster site activation
through compliant, real-time pre-screening
Across all campaigns, OMNI CRS has delivered more than 832,000 qualified leads, including thousands of patients recruited into chronic and metabolic studies relevant to hepatology
How OMNI CRS Delivers Enrollment Excellence
Multi-Channel Outreach
Our precision marketing engine reaches patients across search, social, and provider networks—targeting high-prevalence regions and underrepresented communities with culturally relevant messaging and multilingual materials.
Predictive Data & Pre-Screening
Automated pre-screening tools analyze demographics, medical history, and risk factors to improve match rates and reduce screen failures. Every lead is validated and site-ready.
Compliance & Transparency
Built for HIPAA, GDPR, and FDA compliance, OMNI CRS ensures every campaign meets ethical recruitment standards. Sponsors and CROs gain real-time visibility into recruitment metrics and pipeline progress.
Recruitment Results That Advance Hepatology Research
In liver disease trials where recruitment delays can stall innovation, OMNI CRS has demonstrated measurable performance gains—often 35–40% faster enrollment and up to 50% higher pre-screen match rates compared to industry norms.
By combining empathy-driven communication with automation and analytics, OMNI helps sponsors and sites reach the right patients faster—without compromising compliance or data integrity.
Partner With OMNI CRS to Improve Hepatology Trial Outcomes
Your hepatology trial deserves a recruitment partner that brings speed, precision, and compliance to every campaign. OMNI CRS delivers reliable, scalable enrollment solutions trusted by CROs, pharma, and sites nationwide.